整个蛋白质组的孟德尔随机化揭示了的新型蛋白质标
Zhonghua Xiong1,2,3, Ran Gao4,5, Renxi Wang4,5
1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Current neuropharmacology
|October 20, 2025
概括
这项研究使用了门德尔的随机化来识别29种与有关的血蛋白. 六种优先考虑的蛋白质显示出治疗潜力,对新药开发具有有利的安全概况.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 影响全球超过7000万,目前的治疗方法往往缺乏有效性并引起副作用.
- 对于治疗的新,更安全,更有效的治疗对象有着至关重要的需求.
研究的目的:
- 使用全蛋白质组门德尔随机化 (MR) 方法识别的新型蛋白质标.
- 评估及其亚型的潜在治疗的安全性和特异性.
主要方法:
- 全蛋白质组门德尔随机化 (MR) 综合蛋白质定量特征位点 (pQTL) 和全基因组关联研究 (GWAS) 数据.
- 全现象MR,丰富分析,调解MR和蛋白质-蛋白质相互作用 (PPI) 网络构建被用于验证和途径分析.
主要成果:
- 确定了29种血蛋白,对及其亚型具有假定的因果作用.
- 优先考虑所有的6名候选人,焦点的1名候选人,普遍的12名候选人,具有有利的安全性.
- 发现血代谢物中介于1.6%-22.3%的蛋白质对风险的影响,表明代谢途径的作用.
结论:
- 这项研究提供了强有力的证据,证明了新的蛋白质标对有治疗意义.
- 这些目标具有很高的特异性,机械相关性和功能重叠与现有的抗药物目标,支持翻译价值.
- 这些发现为药物开发和精准医学提供了新的方向.
更多相关视频
08:26Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
Published on: October 19, 2021
6.2K
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
9.0K
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
814
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
Antiepileptic Drugs: Glutamate Antagonists
888
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
888
